Skip to Content
  • Previous Rank
    22
  • Revenues ($M)
    $100,064.60
  • Revenue Percent Change
    -0.2%
  • Profits ($M)
    $4,517.40
  • Profits Percent Change
    32.7%
  • Assets ($M)
    $54,255.80
  • Employees
    26,600
  • Market Value — as of March 29, 2018 ($M)
    $38,790.60

In 2017, pharmacy benefits giant Express Scripts saw its net income skyrocket by 33% year-over-year to $4.51 billion. But a healthy chunk of that income — $1.38 billion — was attributable to the tax law signed by President Donald Trump late last year. While Scripts touted investments in its workforce as a result of the corporate tax cut, it also repurchased 45.9 million of its shares in a stock buyback of nearly $2.95 billion. In 2018, the company will be sure to keep an eye on potential pushback on benefits managers at large, which some critics say contribute to high drug prices because of the industry’s convoluted drug rebate structure. Express Scripts is also in the midst of a proposed $54 billion megadeal to be purchased by insurer Cigna.

41319CFF-E47E-4BA5-B1B8-ECA4D480B0DFCreated with sketchtool.62900797-6A09-46DF-8323-A45758A81292Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

CEO
Timothy C. Wentworth
CEO Title
President, Chief Executive Officer & Director
Sector
Health Care
Industry
Health Care: Pharmacy and Other Services
HQ Location
St. Louis
Websitehttp://www.express-scripts.com
Years on Fortune 500 List19
Employees26,600

Express Scripts Holding Rank History

placeholder

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$100,064.60-0.2%
Profits ($M)$4,517.4032.7%
Assets ($M)$54,255.80-
Total Stockholder Equity ($M)$18,119.60-
Market Value — as of March 29, 2018 ($M)$38,790.60-

Profit Ratios

Profit as % of Revenues4.5%
Profits as % of Assets8.3%
Profits as % of Stockholder Equity24.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)7.74
EPS % Change (from 2016)43.6%
EPS % Change (5 year annual rate)34.5%
EPS % Change (10 year annual rate)21.8%

Total Return

Total Return to Investors (2017)8.5%
Total Return to Investors (5 year, annualized)6.7%
Total Return to Investors (10 year, annualized)7.4%